Ra Medical Systems

$7.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.21 (+2.80%) Today
-$0.02 (-0.26%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RMED and other stocks, options, and ETFs commission-free!

About RMED

Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA. The listed name for RMED is Ra Medical Systems, Inc.

CEO
Jonathan Will McGuire
Employees
79
Headquarters
Carlsbad, California
Founded
2002
Market Cap
21.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
245.76K
High Today
$7.72
Low Today
$7.28
Open Price
$7.28
Volume
302.89K
52 Week High
$67.20
52 Week Low
$4.25

Collections

RMED Earnings

-$1.30
-$0.87
-$0.43
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, After Hours

You May Also Like

HTAB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure